title: Cyclosporine levels in diabetic (type 1) patients undergoing kidney and pancreas transplantation: role of a new galenica formulation.
authors.affiliation: Department of Thoracic and Vascular Surgery, University of Ulm, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Storck
authors.forename: V
authors.initials: V
authors.lastname: Mickley
authors.forename: C
authors.initials: C
authors.lastname: Gräb
authors.forename: G
authors.initials: G
authors.lastname: Steinbach
authors.forename: D
authors.initials: D
authors.lastname: Abendroth
mesh_terms: D000284:Administration, Oral; D000328:Adult; D016572:Cyclosporine / Q000008:administration & dosage / Q000097:blood* / Q000627:therapeutic use; D003922:Diabetes Mellitus, Type 1 / Q000601:surgery*; D003928:Diabetic Nephropathies / Q000601:surgery*; D005260:Female; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D016035:Pancreas Transplantation / Q000276:immunology*; D011863:Radioimmunoassay
chemical_list: D016572:Cyclosporine